Skip to main content
. Author manuscript; available in PMC: 2019 Dec 20.
Published in final edited form as: J Neuromuscul Dis. 2019;6(3):333–339. doi: 10.3233/JND-190404

Table 1:

Clinical features of CMT2U patients with mutations in MARS

This report Hirano et al.
2016
Hyun et al.
2014
Nam et al.
2016
Nam et al.
2016
Gonzalez et
al.2013
Gonzalez et
al.2013
Family 1 2 3 4 5

Variant (NM_004990.3) c.1189G>A c.2398C>A c.2398C>A c.2398C>A c.2398C>A c.1852C>T c.1852C>T
p.Ala397Thr p.Pro800Thr p.Pro800Thr p.Pro800Thr p.Pro800Thr p.Arg618Cys p.Arg618Cys

Age at diagnosis (yrs) 11 69 68 N/A N/A 50 81

Age at onset (years) <1 66 50 5 16 45 67

Sex F F M N/A N/A M M

Motor Symptoms Distal > proximal muscle wasting. Loss of ambulation Very mild toe weakness without muscle atrophy Distal muscle wasting N/A N/A Distal muscle wasting Distal muscle wasting

Sensory Symptoms Mild sensory symptoms Dysesthesia in soles Sensory Loss N/A N/A Stabbing pain in lower limbs Distal sensory loss

Sural Nerve Biopsy N/A Axonal neuropathy N/A N/A N/A Axonal neuropathy N/A